S
Steven T. Pals
Researcher at University of Amsterdam
Publications - 196
Citations - 17692
Steven T. Pals is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Wnt signaling pathway & Cell adhesion molecule. The author has an hindex of 63, co-authored 187 publications receiving 16566 citations.
Papers
More filters
Journal ArticleDOI
Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis.
Gerrit Koopman,Chris P. M. Reutelingsperger,G. A. M. Kuijten,R. M. J. Keehnen,Steven T. Pals,M. H. J. Van Oers +5 more
TL;DR: The results indicate that the phase in apoptosis that is characterized by chromatin condensation coincides with phosphatidylserine exposure, which precedes membrane damage that might lead to release from the cells of enzymes that are harmful to the surrounding tissues.
Journal ArticleDOI
The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells.
Marc van de Wetering,Elena Sancho,Cornelis Verweij,Wim de Lau,Irma Oving,Adam Hurlstone,Karin van der Horn,Eduard Batlle,Damien Coudreuse,Anna-Pavlina G. Haramis,Menno Tjon-Pon-Fong,Petra Moerer,Maaike van den Born,Gwen Soete,Steven T. Pals,Martin Eilers,René H. Medema,Hans Clevers +17 more
TL;DR: The β-catenin/TCF-4 complex constitutes the master switch that controls proliferation versus differentiation in healthy and malignant intestinal epithelial cells.
Journal ArticleDOI
Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway
V. J. M. Wielenga,Ron Smits,Vladimir Korinek,L. Smit,Menno F. Kielman,Riccardo Fodde,Hans Clevers,Steven T. Pals +7 more
TL;DR: In this paper, the authors analyzed CD44 expression in the intestinal mucosa of mice and humans with genetic defects in either APC or Tcf-4, leading to constitutive activation or blockade of the β-catenin/Tcf4 pathway, respectively.
Journal ArticleDOI
The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia
Martin F. M. de Rooij,Annemieke Kuil,Christian R. Geest,Eric Eldering,Betty Y. Chang,Joseph J. Buggy,Steven T. Pals,Marcel Spaargaren +7 more
TL;DR: The data indicate that inhibition of BTK by PCI-32765 overcomes BCR- and chemokine-controlled integrin-mediated retention and homing of malignant B cells in their growth- and survival-supporting lymph node and bone marrow microenvironment, which results in clinically evident CLL regression.
Journal ArticleDOI
EphB receptor activity suppresses colorectal cancer progression
Eduard Batlle,Julinor Bacani,Harry Begthel,Suzanne Jonkeer,Alexander Gregorieff,Maaike van de Born,Núria Malats,Elena Sancho,Elles M. J. Boon,Tony Pawson,Steven Gallinger,Steven T. Pals,Hans Clevers +12 more
TL;DR: It is shown that, although Wnt signalling remains constitutively active, most human colorectal cancers lose expression of EphB at the adenoma–carcinoma transition, and reduction ofEphB activity accelerates tumorigenesis in the colon and rectum of ApcMin/+ mice, and results in the formation of aggressive adenocarcinomas.